Desmoglein-1/Erbin interaction suppresses ERK activation to support epidermal differentiation
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Genetic disorders of the Ras/MAPK pathway, termed RASopathies, produce numerous abnormalities, including cutaneous keratodermas. The desmosomal cadherin, desmoglein-1 (DSG1), promotes keratinocyte differentiation by attenuating MAPK/ERK signaling and is linked to striate palmoplantar keratoderma (SPPK). This raises the possibility that cutaneous defects associated with SPPK and RASopathies share certain molecular faults. To identify intermediates responsible for executing the inhibition of ERK by DSG1, we conducted a yeast 2-hybrid screen. The screen revealed that Erbin (also known as ERBB2IP), a known ERK regulator, binds DSG1. Erbin silencing disrupted keratinocyte differentiation in culture, mimicking aspects of DSG1 deficiency. Furthermore, ERK inhibition and the induction of differentiation markers by DSG1 required both Erbin and DSG1 domains that participate in binding Erbin. Erbin blocks ERK signaling by interacting with and disrupting Ras-Raf scaffolds mediated by SHOC2, a protein genetically linked to the RASopathy, Noonan-like syndrome with loose anagen hair (NS/LAH). DSG1 overexpression enhanced this inhibitory function, increasing Erbin-SHOC2 interactions and decreasing Ras-SHOC2 interactions. Conversely, analysis of epidermis from DSG1-deficient patients with SPPK demonstrated increased Ras-SHOC2 colocalization and decreased Erbin-SHOC2 colocalization, offering a possible explanation for the observed epidermal defects. These findings suggest a mechanism by which DSG1 and Erbin cooperate to repress MAPK signaling and promote keratinocyte differentiation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A quantitative atlas of mitotic phosphorylation
Dephoure, N., Zhou, C., Villén, J., Beausoleil, S. A., Bakalarski, C. E., Elledge, S. J., & Gygi, S. P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805139105 · Cited by 1,608
Ras signalling on the endoplasmic reticulum and the Golgi
Chiu, V. K., Bivona, T., Hach, A., Sajous, J. B., Silletti, J., Wiener, H., Johnson, R. L., Cox, A. D., & Philips, M. R. (2002) · Nature Cell Biology · doi:10.1038/ncb783 · Cited by 594
Molecular Pathogenesis of Chronic Wounds
Stojadinovic, O., Brem, H., Vouthounis, C., Lee, B., Fallon, J., Stallcup, M., Merchant, A., Galiano, R. D., & Tomic-Canic, M. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62953-7 · Cited by 365
Rodriguez-Viciana, P., Oses-Prieto, J., Burlingame, A., Fried, M., & McCormick, F. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.027 · Cited by 215 · cited 1×
“SHOC2 has also been shown to form an M-Ras effector complex with the phosphatase PP1c capable of dephosphorylating an inhibitory Raf site (78).”
Deregulation of keratinocyte differentiation and activation: a hallmark of venous ulcers
Stojadinovic, O., Pastar, I., Vukelic, S., Mahoney, M. G., Brennan, D., Krzyzanowska, A., Golinko, M., Brem, H., & Tomic‐Canic, M. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00321.x · Cited by 145 · cited 1×
“At the level of expression defects, Stojadinovic and colleagues (88–90) indicate that Erbin is downregulated 8 fold in the epider-mis adjacent to chronically wounded, venous ulcers.”
Temporal Smad7 Transgene Induction in Mouse Epidermis Accelerates Skin Wound Healing
Han, G., Li, F., ten Dijke, P., & Wang, X.-J. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.06.003 · Cited by 39
Cited by
Mechanisms of Autoantibody-Induced Pathology
Ludwig, R. J., Vanhoorelbeke, K., Leypoldt, F., Kaya, Z., Bieber, K., McLachlan, S. M., Komorowski, L., Luo, J., Cabral-Marques, O., Hammers, C. M., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00603 · Cited by 469
Immature truncated O-glycophenotype of cancer directly induces oncogenic features
Radhakrishnan, P., Dabelsteen, S., Madsen, F. B., Francavilla, C., Kopp, K. L., Steentoft, C., Vakhrushev, S. Y., Olsen, J. V., Hansen, L., Bennett, E. P., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406619111 · Cited by 313
Sherrill, J. D., KC, K., Wu, D., Djukic, Z., Caldwell, J. M., Stucke, E. M., Kemme, K. A., Costello, M. S., Mingler, M. K., Blanchard, C., et al. (2014) · Mucosal Immunology · doi:10.1038/mi.2013.90 · Cited by 312
Pathophysiology of aniridia-associated keratopathy: Developmental aspects and unanswered questions
Latta, L., Figueiredo, F. C., Ashery-Padan, R., Collinson, J. M., Daniels, J., Ferrari, S., Szentmáry, N., Solá, S., Shalom-Feuerstein, R., Lako, M., et al. (2021) · The Ocular Surface · doi:10.1016/j.jtos.2021.09.001 · Cited by 78
“It has been reported that Desmoglein-1 (DSG1) together with Erbin1 can suppress ERK activation in epidermis [216].”
The Scribble family in cancer: twentieth anniversary
Santoni, M.-J., Kashyap, R., Camoin, L., & Borg, J.-P. (2020) · Oncogene · doi:10.1038/s41388-020-01478-7 · Cited by 62
Metadata
- Authors
- Harmon, R. M., Simpson, C. L., Johnson, J. L., Koetsier, J. L., Dubash, A. D., Najor, N. A., Sarig, O., Sprecher, E., & Green, K. J.
- Venue
- Journal of Clinical Investigation
- Published
- 2013-03-25
- Volume
- 123
- Issue
- 4
- Pages
- 1556-1570
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2120458577
- Cited by
- 136
- References
- 6
- FWCI
- 7.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Desmoglein-1/Erbin interaction suppresses ERK activation to support epidermal differentiation. https://app.cochat.ai/papers/10.1172/jci65220
- The paper
- Harmon, R. M., Simpson, C. L., Johnson, J. L., Koetsier, J. L., Dubash, A. D., Najor, N. A., Sarig, O., Sprecher, E., & Green, K. J. (2013). Desmoglein-1/Erbin interaction suppresses ERK activation to support epidermal differentiation. Journal of Clinical Investigation. https://doi.org/10.1172/jci65220
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.